Mosenzon, Ofri
Blicher, Thalia Marie
Rosenlund, Signe
Eriksson, Jan W
Heller, Simon
Hels, Ole Holm
Pratley, Richard
Sathyapalan, Thozhukat
Desouza, Cyrus
Abramof, R
Alpenidze, D
Aronoff, S
Astamirova, K
Barker, B
Bedel, G
Belousova, L
Benson, M
Beshay, I
Biggs, W
Blaze, K
Bogdanski, P
Busch, R
Chaidarun, S
Chandran, S
Chang, A
Chilka, S
Cleland, A
Connery, L
Cornett, G
Delgado, B
Desouza, C
Donner, T
Eliasson, K
Eriksson, J
Folkerth, S
Forshaw, K
Frandsen, H A
Frolova, E
Gandy, W
Gatipon, G
Golovach, A
Gonzalez-Orozco, L
Gumprecht, J
Haddad, E
Hansen, T K
Hart, T
Hasan, S
Hella, B
Heller, S
Hellgren, M
Hewitt, M
Hietaniemi, S
Hitz, M
Houser, P
Huntley, R
Jackson, R
Jakobsen, P E
Kapoor, A
Kargina, L
Kazakova, E
Khan, K
Klein, E
Knoble, H
Krasnopeeva (Kabachkova), N
Krzeminski, A
Kunitsyna, M
Lawhead, J
Levin, K
Levin, P
Lewy-Alterbaum, L
Lindmark, S
Lindsay, R
Luts, A
Lysenko, T
Madsbad, S
Maxwell, T
Mbogua, C
Mcknight, J
Metsärinne, K
Milovanova, T
Morawski, E
Mosenzon, O
Nabriski, D
Nguyen, H
Nicol, P
Nieminen, S
Nikkola, A
Norwood, P
O'Donnell, P
Odugbesan, A
Parker, J
Pergaeva, Y
Peskov, A
Plevin, S
Pouzar, J
Pratley, R
Reed, J
Rossing, P
Sathyapalan, T
Sergeeva-Kondrachenko, M
Shaikh, Z
Shamkhalova, M
Shehadeh, N
Shlesinger, Y
Silver, R
Snyder, B
Soufer, J
Strand, J
Sulosaari, S
Tirosh, A
Traylor, H
Uhlenius, N
Vagapova, G
Yanovskaya, M
Zarutskaya, L
Zhdanova, E
Funding for this research was provided by:
AstraZeneca
Boehringer Ingelheim
National Institutes of Health
Bristol-Myers Squibb
Novo Nordisk
This article is maintained by: Elsevier
Article Title: Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial
Journal Title: The Lancet Diabetes & Endocrinology
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/S2213-8587(19)30192-5
CrossRef DOI link to the associated document: https://doi.org/10.1016/S2213-8587(19)30182-2
Content Type: article
Copyright: © 2019 Elsevier Ltd. All rights reserved.